- Investing Ideas
- /
- Global Strong Balance Sheet Stocks
Global Strong Balance Sheet Stocks
UPDATED Apr 14, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
31,828 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
SDCI.P | CA$0.065 | 0% | n/a | CA$141.6k | n/a | PB7x | n/a | n/a | Diversified Financials | ||
MFG | AU$9.36 | -1.7% | 20.2% | AU$1.7b | AU$8.82 | PE8.3x | E-13.4% | 6.7% | Diversified Financials | ||
RMS | AU$1.96 | -0.5% | 34.2% | AU$2.3b | AU$1.89 | PE30.4x | E17.6% | 1.0% | Materials | ||
NYM | AU$0.05 | 0% | -44.4% | AU$3.9m | n/a | PS380.8x | n/a | n/a | Materials | ||
AIM | AU$0.36 | -1.4% | 15.9% | AU$77.3m | n/a | PS1.2x | E105.6% | n/a | Commercial Services | ||
6729 | NT$17.20 | -6.8% | 4.2% | NT$432.8m | n/a | PE21.8x | n/a | 8.7% | Materials | ||
2184 | CN¥12.21 | -0.7% | -11.6% | CN¥4.3b | CN¥21.00 | PE26x | E48.1% | 0.8% | Software | ||
688035 | CN¥33.70 | -2.2% | -53.2% | CN¥4.8b | n/a | PE46.6x | E32.1% | 0.9% | Materials | ||
KAC.P | n/a | n/a | n/a | CA$80.0k | n/a | n/a | n/a | n/a | Diversified Financials | ||
4063 | JP¥6,543.00 | 5.7% | 57.5% | JP¥13.0t | JP¥7,080.00 | PE24.3x | E10.1% | 1.5% | Materials | ||
4880 | JP¥1,546.00 | 4.0% | -43.1% | JP¥29.2b | JP¥1,800.00 | PE36x | E21.4% | 0.3% | Pharmaceuticals & Biotech | ||
GRX | AU$0.89 | 0% | 17.2% | AU$248.9m | n/a | PS599.1x | n/a | n/a | Materials | ||
AIV.P | CA$0.04 | 0% | n/a | CA$300.0k | n/a | PB0.3x | n/a | n/a | Diversified Financials | ||
PEB | NZ$0.085 | 3.7% | -81.3% | NZ$71.4m | n/a | PS2.7x | E38.8% | n/a | Pharmaceuticals & Biotech | ||
6919 | JP¥1,872.00 | -0.6% | 7.7% | JP¥13.7b | n/a | PE13x | n/a | 5.4% | Tech | ||
CDNA | US$8.53 | -10.5% | -8.9% | US$441.7m | US$12.50 | PS1.6x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
5132 | JP¥7,280.00 | -9.3% | -2.9% | JP¥19.3b | n/a | PE221.4x | E71.2% | n/a | Software | ||
A199800 | ₩62,400.00 | 4.0% | 26.7% | ₩494.7b | n/a | PS448.3x | n/a | n/a | Pharmaceuticals & Biotech | ||
SNL | AU$19.75 | -0.4% | 52.0% | AU$845.9m | AU$20.23 | PE28.2x | E12.4% | 2.8% | Retail | ||
3666 | JP¥583.00 | 0.3% | 4.1% | JP¥11.3b | n/a | PE9.1x | n/a | 2.7% | Software | ||
KEFI | US$100.00 | 0% | -41.2% | US$116.0m | n/a | PB1.7x | n/a | 1.7% | Banks | ||
531233 | ₹24.90 | -2.7% | 83.0% | ₹775.1m | n/a | PE37.1x | n/a | 0% | Capital Goods | ||
605389 | CN¥22.83 | 9.3% | -22.7% | CN¥3.3b | n/a | PE30x | n/a | 1.5% | Capital Goods | ||
301587 | CN¥38.38 | 1.7% | n/a | CN¥5.7b | n/a | PE41.6x | n/a | n/a | Materials |